Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Other Non-Current Assets (2019 - 2023)

Cyclerion Therapeutics has reported Other Non-Current Assets over the past 5 years, most recently at $1.9 million for Q2 2023.

  • Quarterly results put Other Non-Current Assets at $1.9 million for Q2 2023, down 16.41% from a year ago — trailing twelve months through Jun 2023 was $1.9 million (down 16.41% YoY), and the annual figure for FY2022 was $2.0 million, down 15.21%.
  • Other Non-Current Assets for Q2 2023 was $1.9 million at Cyclerion Therapeutics, down from $2.0 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for CYCN hit a ceiling of $7.7 million in Q2 2019 and a floor of $19000.0 in Q1 2019.
  • Median Other Non-Current Assets over the past 5 years was $2.4 million (2021), compared with a mean of $2.9 million.
  • Peak annual rise in Other Non-Current Assets hit 5473.68% in 2020, while the deepest fall reached 63.76% in 2020.
  • Cyclerion Therapeutics' Other Non-Current Assets stood at $540000.0 in 2019, then skyrocketed by 610.56% to $3.8 million in 2020, then plummeted by 37.27% to $2.4 million in 2021, then decreased by 15.21% to $2.0 million in 2022, then fell by 8.92% to $1.9 million in 2023.
  • The last three reported values for Other Non-Current Assets were $1.9 million (Q2 2023), $2.0 million (Q1 2023), and $2.0 million (Q4 2022) per Business Quant data.